Table 2 The prevalence of hyperuricemia in different gender and area
From: The prevalence of hyperuricemia in China: a meta-analysis
China | Gender | Case/Total (No. of Studies) | Pooled Estimate (%) | 95%CI(%) | Heterogeneity |
|---|---|---|---|---|---|
| Â | Â | Â | Â | Â | I2 P-value |
Northern China | Male | 8923/59413(n = 21) | 19.6 | 15.7-24.1 | 49.8% 0.00 |
| Â | Female | 2393/35231(n = 21) | 8.4 | 6.6-10.5 | 49.2% 0.00 |
Southern China | Male | 44075/163902(n = 34) | 22.7 | 19.6-26.1 | 49.9% 0.00 |
| Â | Female | 17289/132111(n = 35) | 8.8 | 7.1-10.8 | 49.9% 0.00 |
Eastern China | Male | 40056/166093(n = 41) | 20.1 | 17.8-22.6 | 49.8% 0.00 |
| Â | Female | 16645/131127(n = 42) | 8.6 | 7.0-10.6 | 49.8% 0.00 |
Western China | Male | 12942/57222(n = 14) | 26.8 | 17.3-39.0 | 50.0% 0.00 |
| Â | Female | 3037/36215(n = 14) | 8.5 | 6.5-11.2 | 49.5% 0.00 |
Total | Male | 52998/223315 (n = 55) | 21.6 | 18.9-24.6 | 49.9% 0.00 |
| Â | Female | 19586/165620 (n = 55) | 8.6 | 7.2-10.2 | 49.8% 0.00 |